| 000 | 01173 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515234920.0 | ||
| 264 | 0 | _c20111123 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1742-1241 | ||
| 024 | 7 |
_a10.1111/j.1742-1241.2010.02472.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSwift, P A | |
| 245 | 0 | 0 |
_aNot yet time for a paradigm shift away from angiotensin inhibitors in chronic kidney disease, but due diligence required. _h[electronic resource] |
| 260 |
_bInternational journal of clinical practice _cSep 2010 |
||
| 300 |
_a1331-3 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 |
_aAngiotensin Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xprevention & control |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 700 | 1 | _aAndrews, P A | |
| 773 | 0 |
_tInternational journal of clinical practice _gvol. 64 _gno. 10 _gp. 1331-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1742-1241.2010.02472.x _zAvailable from publisher's website |
| 999 |
_c20052308 _d20052308 |
||